Latest News from: Sbarro Health Research Organization (SHRO)

Filters close
Released: 14-Jun-2019 11:05 AM EDT
New Natural Therapeutic Agent to Fight Diabetic Nephropathy
Sbarro Health Research Organization (SHRO)

The extract successfully restored the blood glucose levels, body weight, and normalized oxidative stress on renal function in a test group of Zucker diabetic fatty rats.

Released: 11-Jun-2019 4:10 PM EDT
Exploiting RB1 Predictive Value for Cancer Therapy in the Clinical Setting: Lost in Translation
Sbarro Health Research Organization (SHRO)

RB1 status has emerged not only as a key factor in cancer development and progression, but also as a crucial determinant of cell fate in response to various anticancer treatments

Released: 4-Jun-2019 9:55 AM EDT
Cervical Cancer During Pregnancy, Though Serious, is Highly Treatable According to New Research Review
Sbarro Health Research Organization (SHRO)

“Individualized therapies are strongly recommended and the treatment decision should be made collaboratively with a multidisciplinary team consisting of obstetricians, gynecologists, oncologists, pediatricians, and psychologists,” says researcher.

Released: 20-May-2019 4:05 AM EDT
Brain Cancer Drug Reactivates Body's Natural Defenses
Sbarro Health Research Organization (SHRO)

Drug reactivates p53 tumor suppressor protein and increases chemotherapy effectiveness in potential glioblastoma breakthrough.

Released: 10-Apr-2019 12:05 PM EDT
Enzyme Inhibition May Lead to New Melanoma Therapy, Say Researchers at Fox Chase with Support from Sbarro Institute
Sbarro Health Research Organization (SHRO)

Inhibition of the cellular enzyme thymine DNA glycosylase (TDG) may be an effective treatment for melanoma, according to research published in the journal Oncogene in January. The paper, “Thymine DNA glycosylase as a novel target for melanoma,” describes how inhibition of TDG, known for its role in cell repair and proliferation, may be used to trigger cell death of cancerous melanoma cells and halt tumor growth.

Released: 14-Mar-2019 9:00 AM EDT
Decoy Damaged DNA Discovers New Gene Repair Protein
Sbarro Health Research Organization (SHRO)

A synthetic DNA structure was used as bait to capture nuclear proteins, revealing previously unknown role of HNRNPD in the cellular response to DNA damage.

Released: 4-Feb-2019 11:45 AM EST
Potential to Better Treat Mesothelioma Revealed by Precision Medicine Research
Sbarro Health Research Organization (SHRO)

Researchers have successfully identified two genetic markers for potentially effective treatment of Mesothelioma, an orphan disease most commonly associated with asbestos exposure, and for which few treatments exist.

Released: 11-Dec-2018 7:55 AM EST
Metastatic Breast Cancer Survival Improves with New CDK-Inhibitor Plus Endocrine Therapy
Sbarro Health Research Organization (SHRO)

A study finds that palbociclib, in combination with endocrine therapy, improves progression free survival

Released: 10-Dec-2018 2:05 PM EST
SHRO Partners with Film Festival to Recognize Importance of Virtual Reality in Medicine and Celebrate Italian-Origin Filmmakers
Sbarro Health Research Organization (SHRO)

This week, SHRO partners with the Italian Movie Award International Film Festival to support Italian-American work in cinema, particularly in recognition for accomplishments with the use of Virtual Reality (VR) in applications in medicine

   
Released: 12-Nov-2018 9:00 AM EST
Italian-American Foundation Honors Antonio Giordano, MD, PhD Founder & President of Sbarro Health Research Organization
Sbarro Health Research Organization (SHRO)

Italian-American Foundation, Filitalia, honors Antonio Giordano, MD, PhD, Founder & President of Sbarro Health Research Organization at Temple University with the Humanitarian award at the foundation’s 31st Anniversary Gala.

   
Released: 13-Oct-2018 2:00 PM EDT
Dompé at the medical conference “The Impact of Environment and Healthy Lifestyles in Human Health” - October 13th, Washington, D.C
Sbarro Health Research Organization (SHRO)

Sbarro Health Research Organization, on the occasion of the medical conference “The impact of environment and healthy lifestyles in human health,” honoured Nathalie Dompé, CEO Dompé Holdings, with a special Award for Societal Impact in Business & Biotechnology, for her work and effort in promoting social responsibility.

Released: 3-Oct-2018 9:00 AM EDT
Medical Conference: The Impact of Environment and Healthy Lifestyles in Human Health
Sbarro Health Research Organization (SHRO)

The medical conference is organized by the Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano Foundation

Released: 2-Oct-2018 9:00 AM EDT
Healthier Planet, Healthier People, and More Innovative Medical Science with Italian-American Researchers at Annual NIAF Convention
Sbarro Health Research Organization (SHRO)

Foundation Awards Presented for Ethics and Creativity in Medical Research, and Societal Impact in Business & Biotechnology

Released: 24-Aug-2018 1:45 PM EDT
New MicroRNA Target May Inhibit Mesothelioma and Unveils Method to Identify Potential Treatments
Sbarro Health Research Organization (SHRO)

Inhibition of miR-24-3p reduced growth of cancer cells and was found to regulate proteins as a potential treatment target for Mesothelioma (MPM). The new potential target, and the method researchers have used to identify it, is an important step in addressing this challenging disease.

Released: 12-Jun-2018 2:05 PM EDT
Olive Oil Production Threatened by New Deadly Plant Pathogen Recently Introduced to Europe
Sbarro Health Research Organization (SHRO)

One of the iconic ingredients of the Mediterranean diet, which often has been associated with beneficial effects in the prevention of cancer as well as several other disorders, is extra-virgin olive oil. For thousands of years, olive trees were planted on Mediterranean coasts, initially by ancient Greek colonists, followed by several other civilizations and cultures, one generation after the other.

Released: 29-May-2018 3:30 PM EDT
In Debate of Scheduled Versus Spontaneous Exercise, Which Motivates You More?
Sbarro Health Research Organization (SHRO)

Older adults seem to be more motivated by scheduled workouts, including the role of a fitness coach or a significant person involved in their exercise goals, when compared to those getting exercise only through spontaneous physical activity.

   
Released: 2-Apr-2018 9:00 AM EDT
Molecular Inhibitors Can Boost Natural Tumor Suppression to Fight Lung Cancer and Mesothelioma
Sbarro Health Research Organization (SHRO)

Inhibition of the oncogenic kinase AKT, a key protein governing the cell cycle, was found to arrest cancer cell proliferation and triggered their programmed death by apoptosis. The study, published today in Oncogene, represents significant progress in the clinical translation of previous basic scientific discoveries.

Released: 9-Mar-2018 8:55 AM EST
Virtual Reality: An Escape From Painful and Stressful Medical Treatments
Sbarro Health Research Organization (SHRO)

VR has shown promise in several clinical trials assessing its possible utility as a distraction tool to alleviate pain and distress during medical procedures.

Released: 6-Mar-2018 8:55 AM EST
Repurposed Parasite Drug New Weapon Against Mesothelioma
Sbarro Health Research Organization (SHRO)

Anthelmintic drug already approved to treat infections of pinworm parasite was shown to effectively impair both mesothelioma cell growth and migration.

Released: 1-Mar-2018 9:00 AM EST
Diverse Role of CDK9 Gene in Cell Regulation Continues to Reveal Cancer Treatment Targets 25 Years After Discovery
Sbarro Health Research Organization (SHRO)

A gene discovered by Temple University researchers has proved to be an important target for cancer therapy, with the discovery of its roles in controlling cell proliferation, differentiation, apoptosis, and DNA repair.

Released: 17-Jan-2018 4:05 PM EST
Fluctuations of Sex Steroid Hormone Could be Culprit in Age-Related Macular Degeneration
Sbarro Health Research Organization (SHRO)

Gender-based differences may influence several ocular conditions, suggesting that fluctuations in sex steroid homeostasis may have direct effects on eye physiology and the pathogenesis of conditions like Age-Related Macular Degeneration (AMD).

Released: 2-Jan-2018 9:00 AM EST
Detecting Pompe Disease with More Accuracy Key to Urgent Intervention
Sbarro Health Research Organization (SHRO)

Researchers identified a new, more sensitive screening test to recognize Pompe disease, a metabolic disorder affecting cellular processing of glycogen in numerous tissues of the body.

Released: 21-Dec-2017 2:30 PM EST
Xylella: A Conscience, Not a Science Problem
Sbarro Health Research Organization (SHRO)

The Sbarro Health Research Organization congratulates the Italian researchers who were able to prove a direct causal link between the infection by Xylella fastidiosa and the death of olive trees in southern Italy.

Released: 4-Dec-2017 8:55 AM EST
From Medical Discovery to Food and Fine Arts, Italian-American Contributions Celebrated at Annual Foundation Conference
Sbarro Health Research Organization (SHRO)

At this year’s 42nd annual NIAF Gala Weekend at the Washington Marriott Wardman Park Hotel in D.C., all aspects of Italian heritage were celebrated, including food, the fine arts, and scientific discovery. The weekend’s events included the medical conference, “Mediterranean Diet, Human Health and Longevity,” sharing the latest in research into a vital part of Italian culture –– diet and food. Conference presentations explored how the recipes of Italian grandmothers are among the healthiest in the world and can even help fight disease, such as cancer.

   
Released: 27-Nov-2017 9:00 AM EST
New Cancer Therapies Earn Sbarro Health Research Organization President Antonio Giordano 2017 CORE Prize for Oncology
Sbarro Health Research Organization (SHRO)

The CORE Prize for Oncology 2017 was awarded to Professor Antonio Giordano for his groundbreaking discoveries in the field of the cell cycle, which have established an understanding of the fundamental mechanisms at the basis of cancer and the development of a new class of anticancer therapeutics.

Released: 31-Oct-2017 4:05 PM EDT
Italian-American Researchers Present Mediterranean Diet, Health, and Longevity at Annual Medical Conference
Sbarro Health Research Organization (SHRO)

Sbarro Health Research Organization President Antonio Giordano introduces program at National Italian American Foundation 42nd Anniversary Gala Weekend In Washington D.C.

Released: 5-Sep-2017 9:00 AM EDT
Research Reveals Gene Differences in Mouse Model Versus Humans
Sbarro Health Research Organization (SHRO)

Aspects of gene function in humans can be predicted by studies of the corresponding gene in mice, but new research findings have revealed important divergences between the species which scientists will need to understand better through further investigation.

Released: 25-Aug-2017 11:05 AM EDT
Adding Radiation Treatments to Inoperable Lung Cancer Increases Survival by up to One Year
Sbarro Health Research Organization (SHRO)

Patients with unresectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years. Researchers exploring combination therapies have recently discovered improved survival rates by up to one year when patients treated with a newly formulated chemotherapy regimen are also given radiation therapy.

Released: 23-Aug-2017 4:55 PM EDT
Targeting Cell Cycle Reactivation Caused by Inflammation May Provide the Way to Prevent Neuron Death in Alzheimer’s Disease
Sbarro Health Research Organization (SHRO)

Researchers have discovered a clue to the mechanism for neuronal degeneration and possible target for a therapeutic approach to these disorders.

Released: 7-Aug-2017 11:05 AM EDT
Does Radiology Contrast Medium Matter? To Fragile Cancer Patients, Yes
Sbarro Health Research Organization (SHRO)

Given the choice of contrast medium for a computed tomography (CT) scan, most patients wouldn’t know the difference between the two iodine-based options commonly used in cancer cases. But for some patients, particularly in the already fragile and potentially compromised cancer patient, it is important to be aware that iodated contrast media has been linked to kidney impairment and a condition known as Contrast-induced nephropathy (CIN).

Released: 25-Jul-2017 11:05 AM EDT
Clinical Data Confirms Efficacy of Pre-Surgery Chemo in Triple-Negative Breast Cancer
Sbarro Health Research Organization (SHRO)

Researchers analyzed data confirming the improved outcomes in both short- and long-term survival in patients that underwent neoadjuvant chemotherapy prior to surgery for triple-negative breast cancer. The study included 213 patients at 8 Italian cancer centres whose diagnoses were characterized by clinical, molecular, and therapeutic features of triple-negative breast cancer, an aggressive form of cancer with limited treatment options.

Released: 30-May-2017 7:05 AM EDT
Unexpected Presence of Glucose Receptor in Ovarian Cancer Links Metabolism to Most Aggressive Cases
Sbarro Health Research Organization (SHRO)

A new study of non-diabetic women with ovarian cancer reveals a potential correlation and area for further study regarding the expression of the GLUT1 glucose transporter receptor at the cancer tissue level. GLUT1 is a receptor protein involved in the absorption of glucose, or sugar, in the bloodstream and across membranes in the body.

Released: 13-May-2017 12:05 AM EDT
Tomato Extract Fights Stomach Cancer, Ripe for Further Study
Sbarro Health Research Organization (SHRO)

A new study suggests that the use of tomato — a key food of the Mediterranean diet — should be explored to develop supportive strategies against gastric cancer

Released: 13-Apr-2017 7:05 AM EDT
Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert
Sbarro Health Research Organization (SHRO)

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.

Released: 29-Mar-2017 2:05 PM EDT
Sbarro Health Research Organization President Re-Elected to Board of Italian American Foundation
Sbarro Health Research Organization (SHRO)

Giordano is joined on the board by Corporation for Public Broadcasting President and CEO Patricia de Stacy Harrison and former Talk America President, Chairman and CEO Gabriel A. Battista who will serve as co-chairperson of the Foundation

Released: 7-Mar-2017 1:00 PM EST
Economic Disparities a Growing Concern for Cancer Diagnosis and Treatment
Sbarro Health Research Organization (SHRO)

The most recent global cancer data from the WHO highlights the growing differences in mortality rate among regions of the world bearing very different economic circumstances.

Released: 21-Feb-2017 1:05 PM EST
Actors with Disabilities Go to Hollywood Festival, Sbarro Health Research Org Praises Filmmakers
Sbarro Health Research Organization (SHRO)

The organization is praising a group of Italian filmmakers for their contribution to medicine through the arts. Their film, Ho Amici In Paradiso [I Have Friends in Heaven], will screen this week at the Los Angeles Italia Film, Fashion, and Art Fest.

   
Released: 17-Feb-2017 3:05 PM EST
Micro-RNA May Amplify Effectiveness of Sorafenib in Difficult Liver Cancer Cases
Sbarro Health Research Organization (SHRO)

Only 25% of patients respond to sorafenib treatment, so researchers have endeavored to understand its mechanism of action and discover a way to boost its effectiveness.

Released: 8-Feb-2017 10:30 AM EST
Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert
Sbarro Health Research Organization (SHRO)

“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.

Released: 19-Jan-2017 3:05 PM EST
Molecular Subgroups of Non-Small Cell Lung Cancer Predict Tumor Behavior, Reveal Treatment Targets
Sbarro Health Research Organization (SHRO)

EGFR mutations is associated with a longer median overall survival (almost double) compared with those without EGFR mutations when treated with specific targeted agents.

Released: 30-Nov-2016 1:05 PM EST
Treatment Combination to Improve Survival in HER2-Negative Metastatic Breast Cancer
Sbarro Health Research Organization (SHRO)

The study, “A Real-World Multicentre Retrospective Observational Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line Treatment for HER2-Negative Metastatic Breast Cancer,” was recently published in the Journal of Cell Physiology.

Released: 31-Oct-2016 9:00 AM EDT
New Study ‘Sheds Light’ on the Mechanisms Safeguarding the Genome
Sbarro Health Research Organization (SHRO)

Understanding the molecular mechanisms that exist for cells to safeguard their genome against cancer-causing defects is crucial not only to understand how cancer arises but also because these mechanisms can be targeted therapeutically. Researchers have identified a new net of molecular interactions occurring within cells upon exposure to DNA damaging UV radiation. The team lead by Antonio Giordano, MD, PhD, Director and Founder of the Sbarro Health Research Organization at Philadelphia, PA , published their findings in Oncotarget.

Released: 26-Oct-2016 1:05 PM EDT
Researchers Slow Glioblastoma by Inhibiting Tumor’s PPARα Receptor
Sbarro Health Research Organization (SHRO)

One of the most remarkable features of glioblastoma is the metabolic reprogramming of cancerous cells, resulting in uncontrolled cell proliferation, hypoxic conditions and angiogenesis. Metabolic reprogramming enables tumor cells with a faster way to produce energy and form new membranes. For this and other reasons, glioblastoma is presently incurable and the affected patients have a poor outcome.

Released: 12-Oct-2016 1:05 PM EDT
Women Leaders in Advanced Cancer Research
Sbarro Health Research Organization (SHRO)

The Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano Foundation will host the medical conference “Women Leaders in Advanced Cancer Research” 9 A.M on Saturday, October 15th at the Marriot Wardman Park Hotel in Washington, D.C.

Released: 3-Oct-2016 2:05 PM EDT
New RNA Stem Cell Editing Reduces Unintended Genetic Complications
Sbarro Health Research Organization (SHRO)

An international collaboration of government, university, and industry resources showed the promise of using RNA as a safe way to both make and modify induced Pluripotent Stem Cells (iPSCs) from patient cells for clinical applications in regenerative medicine, tissue engineering, and personalized medicine.

   
Released: 20-Jul-2016 9:40 AM EDT
The Complex Crosstalk Between Obesity and Breast Cancer
Sbarro Health Research Organization (SHRO)

A new study published in the Journal of Cell Physiology describes how inflammation that characterizes fatty tissue is one of the main microenvironment actors responsible for promoting cancer. The authors also describe the involvement of steroid hormones and others factors produced by adipose tissue in breast cancer development.

Released: 20-May-2016 2:05 PM EDT
Concurrent Administration of Antrhacyclines and Trastuzumab in Breast Cancer Patients: New Findings for an Old Challenge
Sbarro Health Research Organization (SHRO)

USA-ITALY May 2016. The study entitled “A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. The DECT trial” has recently appeared in the Journal of Cell Physiology, an international, per-reviewed journal focused on cancer-related issues. The authors belong to a multidisciplinary Italian-American team with a long and productive history of collaboration with Prof. Antonio Giordano, Director of the Sbarro Institute for Cancer Research of Philadelphia, Temple University Pennsylvania, USA and the Department of Medicine Surgery and Neuroscience at University of Siena.


Showing results 101–150 of 211


close
0.8519